HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Clinical research of second resection on early stage primary bladder adenocarcinoma and literature review].

AbstractOBJECTIVE:
To investigate the clinical and pathological characteristics, as well as the diagnosis and treatment of primary bladder adenocarcinoma in the early stage.
METHODS:
The clinical features, pathological results, diagnosis and treatment profiles of 7 cases of primary bladder adenocarcinoma admitted in Affiliated Hospital of Nantong University from January 2010 to July 2015 were analyzed ret rospectively.
RESULTS:
All seven cases were diagnosed pathologically as primary bladder adenocarinoma.Histological staging T1 was revealed in six cases, while T2 in one case after the first resection.After four weeks, all patients received the second resection while one patient underwent immediately radical cystectomy. Multimodality therapy such as radiotherapy or chemotherapy was performed for longer postoperative survival.only one man died while another patient had been healthy for 6 years till January 2016.
CONCLUSION:
Primary bladder adenocarcinoma is a highly malignant disease in bladder cancer.According to the results of the second resection, multimodality therapy for patients in early stage with no lymph node or other organs metastasis can improve the quality of life without affectiong their lives.
AuthorsQ W Xing, Y Wu, B Cai, L M Ma, B Cheng, Y P Zhang
JournalZhonghua yi xue za zhi (Zhonghua Yi Xue Za Zhi) Vol. 96 Issue 20 Pg. 1585-7 (May 31 2016) ISSN: 0376-2491 [Print] China
PMID27266688 (Publication Type: Journal Article, Review)
Topics
  • Adenocarcinoma (pathology, surgery)
  • Combined Modality Therapy
  • Cystectomy
  • Humans
  • Lymph Nodes
  • Male
  • Prognosis
  • Quality of Life
  • Retrospective Studies
  • Treatment Outcome
  • Urinary Bladder Neoplasms (pathology, surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: